转录组评估空心微针介导的药物输送,用于类风湿性关节炎治疗
Zhibo Liu1, Xiaotong Li1, Suhang Liu1
1State Key Laboratory of Optoelectronic Materials and Technologies, Guangdong Province Key Laboratory of Display Material and Technology, School of Electronics and Information Technology, Sun Yat-sen University, Guangzhou 510006, China.
Biosensors
|December 24, 2025
概括
在临床前模型中,微针阵列有效地提供托法西替尼和N-乙半氨酸 (NAC) 来治疗类风湿性关节炎 (RA). 这种局部药物递送减少了炎症和软骨损伤,显示了针对性RA治疗的前景.
科学领域:
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 需要长期管理,通常是通过口服药物引起全身副作用.
- 传统的RA治疗可能会导致系统性药物分发的不良影响,影响疗效.
- 微针阵列为局部药物输送提供了一种最少的侵入性方法,绕过全身循环.
研究的目的:
- 评估空心微针阵列输送托法西替尼和N-乙半氨酸 (NAC) 治疗类风湿性关节炎 (RA) 的疗效和安全性.
- 通过使用多层次分析,在RA模型中研究基于微针治疗的机制基础.
- 建立RA管理中精确向治疗的计算和机制基础.
主要方法:
- 对炎症和软骨退化的组织学评估 (H&E,Safranin O-Fast Green).
- 微计算机断层扫描 (micro-CT) 用于评估骨结构的变化.
- 针对细胞因子和氧化应激标记物的ELISA,以及用于基因表达分析的转录基因分析.
主要成果:
- 托法西提尼布和NAC的微针输送表明,RA相关的炎症和软骨退化显著减少.
- 分子分析揭示了关键炎症和氧化应激路径的调节.
- 转录形状分析确定了特定的基因表达变化和对治疗有反应的信号通路.
结论:
- 空洞的微针阵列提供了一个有效和安全的平台,用于局部提供RA治疗药物.
- 这项研究验证了微针技术用于RA的向治疗策略.
- 这些发现支持基于微针的药物输送作为慢性炎症疾病精准医学的一个有希望的方法.
相关概念视频
Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...


